The expression of inducible nitric oxide synthase (NOS2) is complex and is regulated in part by gene transcription. In this investigation we studied the regulation of NOS2 in a human liver epithelial cell line (AKN-1) which expresses high levels of NOS2 mRNA and protein in response to tumor necrosis factor a, interleukin 113, and interferon y (cytokine mix, CM). Nuclear run-on analysis revealed that CM transcript"onally activated the human NOS2 gene. To delineate the cytokine-responsive regions of the human NOS2 promoter, we stimulated AKN-1 cells with CM following transfection of NOS2 luciferase constructs. Analysis of the first 3.8 kb upstream of the NOS2 gene demonstrated basal promoter activity but failed to show any cytokine-inducible activity. However, 3-to 5-fold inductions of luciferase activity were seen in constructs extending up to -5.8 and -7.0 kb, and a 10-fold increase was seen upon transfection of a -16 kb construct.' Further analysis of various NOS2 luciferase constructs ligated upstream of the thymidine kinase promoter identified three regions containing cytokine-responsive elements in the human NOS2 gene: -3.8 to -5.8, -5.8 to -7.0, and -7.0 to -16 kb. These results are in marked contrast with the murine macrophage NOS2 promoter in which only 1 kb of the proximal 5' flanking region is necessary to confer inducibility to lipopolysaccharide and interferon y. These data demonstrate that the human NOS2 gene is transcriptionally regulated by cytokines and identify multiple cytokineresponsive regions in the 5' flanking region of the human NOS2 gene.
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Nitric oxide (NO) is a potent effector molecule which is involved in a multitude of physiological activities ranging from the regulation of vascular tone and neurotransmission to the killing of microbes or tumor cells (1) . NO is synthesized by the enzyme nitric oxide synthase (NOS) from an L-arginine substrate. Three isoforms of NOS enzymes have been characterized, two or which are constitutively expressed and a third which is inducible (2) . The constitutive enzymes, neuronal NOS (NOSI) and endothelial NOS (NOS3), are calcium-calmodulin dependent and intermittently produce small amounts of NO that mediate processes such as vasorelaxation and neurotransmission. The inducible NOS (iNOS, NOS2) protein has enzymatic activity that is not dependent on elevations in calcium above basal intracellular levels. NOS2 is typically not present in unstimulated cells but is expressed in response to cytokines, lipopolysaccharide (LPS), and a host of other agents (3) . In contrast to the two constitutive enzymes, NOS2 produces large, sustained amounts of NO that display both cytotoxic and cytoprotective effects.
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Recent reports, however, have challenged this paradigm of constitutive and inducible NOS expression. Studies have shown that the two cNOS isoforms are inducible in certain settings (4, 5) . Conversely, it appears that NOS2 may also be constitutively expressed in some tissues and cell types, such as the large airways of humans and certain human mononuclear cell lines (6, 7) . These observations demonstrate the complexity of gene expression of the different NOS enzymes and lend credence that NOS expression, whether constitutive or inducible, is not just limited to features of the gene for a specific isoform but also to the cell type and stimulus involved in NOS expression.
Our own studies have indicated that the regulation of cytokine-induced NO synthesis in hepatocytes is under complex control. We previously showed that tumor necrosis factor a (TNF-a), interleukin 1,3 (IL-1,8), interferon y (IFN--y), and LPS synergistically induce NOS2 gene expression in vitro in both rat and human hepatocytes (8) (9) (10) . Among the cytokines, 8 is the most effective single stimulus to induce NOS2 expression in primary rat or human hepatocyte cultures (11) . These studies led us to clone the cDNA (12) and gene (13) for human hepatocyte NOS2, providing conclusive evidence that NOS2 can be expressed in human cells. In vivo, we have shown that rat hepatocytes produce NO during endotoxemia and chronic liver inflammation (14, 15) . In rodent studies using a nonselective NOS inhibitor, we have found that NO exerts a protective effect in the liver during endotoxemia by preventing the formation of microthrombi and by neutralizing radical oxygen intermediates (16, 17) . We have also determined that NOS2 expression in rat hepatocytes is differentially regulated from the acute phase response (14) and is inhibited by steroids (10) as well as the heat shock response (M.E.d.V., T.R.B., and D.A.G., unpublished data).
The cytokine and endotoxin induction of rodent NOS2 involves the transcriptional activation of the NOS2 gene (11, (18) (19) (20) (21) . Attempts to elucidate the molecular mechanisms underlying this induction have led to the characterization of the 5' regulatory region of the murine macrophage NOS2 gene (22, 23) . Two functional regulatory elements of the murine NOS2 promoter have recently been found to reside within 1 kb of the transcription start site (24, 25) . There are, however, major differences in sequence and potential cis-acting elements between the human and rodent NOS2 5' flanking Abbreviations: TNF-a, tumor necrosis factor a; IL-1,B, interleukin 1(3; IFN--y, interferon -y; CM, cytokine mixture (TNF-a/IL-113/IFN--y); NO (27) .
Northern Blot and Nuclear Run-on Analyses. RNA extraction, Northern blot hybridization, and autoradiography were performed as described (9) . Relative mRNA levels were quantitated on a Phorphorlmager scanner (Molecular Dynamics) using IMAGEQUANT software. For nuclear run-ons, nuclei were isolated and in vitro transcription was performed as described elsewhere (11) . Sense and antisense cRNA probes were generated for the full-length NOS2 cDNA (12) synergism between the three cytokines (Fig. 1B). IFN-- To determine whether the CM-induced increase in NOS2 mRNA levels involved transcriptional activation of the gene, nuclear run-on assays were performed. CM increased NOS2 gene transcription by 5-fold at the 2-hr and 4-hr time points (Fig. 2) . Unstimulated AKN-1 cells exhibited basal NOS2 transcription, a finding which we have previously noted in cultured rat hepatocytes (11) . Consistent with the absence of NOS2 mRNA in unstimulated AKN-1 cells (Fig. 1) (Fig. 3) . Transient transfections of the NOS2-luciferase constructs into AKN-1 cells and stimulation with CM revealed no significant induction of luciferase activity in constructs containing only the first 3.8 kb of the 5' flanking region (Fig. 3) . However, transfection of pNOS2(5.8)Luc and pNOS2(7.0)Luc followed by CM stimulation resulted in 3-fold and 5-fold induction in luciferase activity, respectively. This 5-fold induction in promoter activity is similar in magnitude to the endogenous transcriptional activation of NOS2 seen in the nuclear run-on experiments (Fig. 2) Identification of cytokine-responsive regions was confirmed in independent experiments in which NOS2 constructs were cotransfected with the internal reference plasmid pIEP-lacz to eliminate the possibility that any cytokine-dependent increase in luciferase activity merely reflected differences in transfection efficiency rather than increases in transcription rate (not shown).
We consistently noted low levels of luciferase expression in unstimulated AKN-1 cells transfected with the various NOS2 constructs (Fig. 3, compare with pXP,) , indicating basal promoter activity in the absence of cytokine stimulation. For comparison, transfection of pRSV-Luc resulted in luciferase activity averaging 15,000 u/,ug of protein in unstimulated AKN-1 cells (not shown).
In order to further localize cytokine-responsive regions, AKN-1 cells were transfected with pNOS2(5.8)Luc, pNOS2(7.0)Luc, and pNOS2(16)Luc and stimulated with various combinations of cytokines at the standard CM concentrations. TNF-a, IL-1,B, or IFN-y alone did not elicit any significant changes in luciferase activity (Fig. 4) . TNF-a/IL-1fI or TNF-a/IFN--y induced a 2-to 3-fold increase in luciferase activity in all three constructs. IL-1i3/IFN--y elicited a modest 2-fold increase in luciferase expression with pNOS2(5.8)Luc. However, a greater increase in luciferase activity (7- fold and 9-fold) was noted with pNOS2(7.0)Luc and pNOS2 (16) (Fig. 5) . Reporter gene assays showed a 2-fold induction of luciferase activity with pNOS2(3.8-5.8)TK-Luc. Analysis of pNOS2(5.8-7.0)TK-Luc and pNOS2(7.0-16)TKLuc indicated a 2-fold and 6-fold increase in luciferase expression, respectively. These results confirm the presence of func- 
DISCUSSION
In the present investigation, we describe our initial attempt to characterize the human NOS2 promoter in a cytokineresponsive human liver epithelial cell line (AKN-1). Cytokine (TNF-a/IL-1f3/IFN--y) stimulation of AKN-1 cells induced NOS2 expression in a time-dependent manner (Fig. 1A ) similar to the time course of NOS2 induction that we previously reported in primary human hepatocytes (9) . Furthermore, the use of a combination of cytokines showed additive or synergistic effects for induced NO synthesis in the AKN-1 cell line (Fig. 1B) , a finding also seen in primary human hepatocytes (10) . These results show that cytokine-induced NOS2 expression in AKN-1 cells is similar to NOS2 induction in primary human hepatocyte cultures and indicate that the AKN-1 cell line is likely to be a useful reproducible model in which to study the molecular regulation of the human NOS2 gene. It is important to point out that some qualitative differences between AKN-1 cells and primary human hepatocytes were observed. IFN--y was the most effective single cytokine to stimulate NOS2 expression in the AKN-1 cells (Fig. 1B) , whereas IL-113 was the most effective cytokine in the primary hepatocytes (11) . Further studies are required to determine whether the differences in NOS2 induction are due to variable expression of cytokine receptors or cell-specific differences in NOS2 gene transcription factors.
Nuclear run-on assays with CM-stimulated AKN-1 cells showed an =5-fold increase in NOS2 transcription rates compared to unstimulated cells (Fig. 2) . These data indicate that the human NOS2 gene is regulated in part at the level of transcription. Parallel reports have shown that the regulation of the rodent NOS2 gene also involves transcriptional activation (11, (18) (19) (20) (21) . Studies elucidating the molecular mechanisms involved in the transcriptional regulation of NOS2 have been reported only for murine macrophages. Two regions in the murine macrophage NOS2 promoter have been shown to be essential for conferring inducibility of mac-NOS2 to LPS and IFN--y (22, 23 ). An NF-KB element at positions -76 to -85 was found to bind members of the NF-KB/Rel family of proteins in response to LPS (24 (13) . However, this homology decreases to only 47% when the first 1.5 kb of both promoters are compared, suggesting that differences in gene regulation may prove to exist (data not shown). Computer analysis reveals the presence of >30 putative elements in this 1.5-kb region, including several copies of NF-KB, IFN-,y-responsive elements (IRF-1, ISRE, GAS), and TNF-responsive elements. Yet, AKN-1 cells transfected with a series of NOS2-luciferase gene constructs exhibited no significant activity in the first 3.8 kb of the 5' flanking region upon stimulation with CM (Fig. 3) , demonstrating a marked contrast with the murine NOS2 gene in macrophages, wherein only 1 kb of the proximal 5' flanking region is required for LPS and IFN--y induction. Cytokine-inducible activity was initially noted with pNOS2(5.8)Luc, indicating the presence of cytokine-responsive regulatory elements between -3.8 and -5.8 kb. Further induction of luciferase activity was noted in constructs extending to -7.0 and -16 kb. In addition, our transfection studies indicate that IL-1,B and IFN-y-responsive elements exist in the region between -5.8 and -7.0 kb (Fig. 4) . To further confirm the presence of cytokine-responsive motifs upstream of -3.8 kb, we assessed the ability of these regions to confer cytokine responsiveness to the thymidine kinase promoter. Transfection assays demonstrated the presence of cytokineresponsive regulatory elements in the regions between -3.8 and -16 kb (Fig. 5) . Thus, the cytokine-induced increase in human NOS2 transcription rates in AKN-1 cells requires elements upstream of -3.8 kb to sustain high levels of promoter activity. As yet unknown from these initial studies are the specific elements required for transcriptional activation and what regions, if any, in the proximal promoter are also required.
The promoter inducibility of human NOS2 that we obtained in this study was less than that reported for the murine NOS2 promoter in RAW 264.7 cells treated with LPS/IFN-,y (22, 23) .
We have carried out transfection studies with the 1.5 kb murine promoter-luciferase construct (22) in LPS/IFN--ytreated RAW 264.7 cells and obtained 6-to 7-fold increases in luciferase expression (M.E.d.V., T.R.B., and D.A.G., unpublished data). It is unclear why we found lower levels of inducibility in the murine system, although it is most likely due to different transfection techniques, the use of different reporter genes, and different culture and stimulation conditions. Nevertheless, this level of induction of murine NOS2 promoter activity that we obtain is comparable to our 5-fold induction in promoter activity using pNOS2(7.0)Luc in AKN-1 cells. Furthermore, our transfection results are very consistent with the endogenous 5-fold increase in NOS2 transcripts that we see in our nuclear run-on assays.
We consistently measured low levels of promoter activity even in the absence of cytokine stimulation. This could simply reflect the fact that transfected NOS2 constructs do not have the chromatin structure of the endogenous NOS2 gene and also are present in much higher copy number than the endogenous NOS2 gene. However, a second possibility is that the human NOS2 gene may actually be transcriptionally activated to a small degree in resting cells. Nuclear run-on assays support this notion in that NOS2 transcripts are present in unstimulated cells, indicating a low-level, "constitutive" expression of NOS2 (Fig. 2) . We have noted this phenomenon also in primary rat hepatocytes (11) , and this has been demonstrated in murine peritoneal macrophages as well (32 (6) . Whether this basal expression reflects the chronic exposure of these cells to inflammatory stimuli is not known. Furthermore, human Epstein-Barr virus-infected lymphocytes and Burkitt lymphoma cell lines also express NOS2 in the absence of cytokine stimulation (7) . NO appears to play a role in inhibiting lymphocyte apoptosis and in preventing viral reactivation in these cells. Whether the regulation of NOS2 expression in these settings is different from cytokine-induced NOS2 expression is unknown and warrants separate analysis.
These data indicate that the human NOS2 gene is regulated by a complex promoter-regulatory region which, in contrast to the murine macrophage NOS2 gene, requires cytokineresponsive elements upstream of -3.8 kb to increase its transcriptional activity. It is important to note that no one has examined regions of the murine NOS2 gene that are further upstream of -1.5 kb to determine whether additional regions are increasing NOS2 promoter activity. Based on our observations here, it would be reasonable to speculate that such elements could exist in the murine promoter. Although other genes in the liver such as albumin and a-fetoprotein contain enhancers thousands of base pairs proximal to the gene (34, 35) , these and most other genes also contain inducible promoter elements within the first I kb of the transcriptional start site. We 
